What is the recommended treatment for chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Chlamydia

The recommended first-line treatment for uncomplicated chlamydial infection is either azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days, with both regimens having similar efficacy rates of approximately 97-98%. 1

First-Line Treatment Options

  • Azithromycin 1 g orally in a single dose

    • Advantages: Single-dose therapy, directly observed treatment possible, better compliance 1
    • Particularly useful when compliance with multi-day regimens is questionable 1
    • Microbial cure rate of approximately 97% 1, 2
  • Doxycycline 100 mg orally twice daily for 7 days

    • Advantages: Lower cost, extensive clinical experience 1
    • Microbial cure rate of approximately 98% 1, 3
    • Standard dosage is 100 mg twice daily for 7 days for uncomplicated chlamydial infections 4

Alternative Treatment Options

  • Erythromycin base 500 mg orally four times a day for 7 days 1, 5
  • Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 1
  • Ofloxacin 300 mg orally twice a day for 7 days 6, 1
  • Levofloxacin 500 mg orally once daily for 7 days 6, 1

Special Populations

Pregnant Women

  • Azithromycin 1 g orally in a single dose 6, 1
  • Amoxicillin 500 mg orally three times a day for 7 days 6, 1
  • Erythromycin base 500 mg orally four times a day for 7 days (if unable to tolerate azithromycin or amoxicillin) 6, 1
  • Note: Doxycycline and ofloxacin are contraindicated during pregnancy 6, 1

Children

  • For children ≥8 years who weigh >45 kg: Azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days 6
  • For children ≥8 years who weigh <45 kg: Doxycycline 2 mg/kg body weight twice daily for 7 days 6, 4
  • For children <8 years: Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days 6

Implementation Considerations

  • Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance 1
  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 1
  • All sex partners from the previous 60 days should be evaluated, tested, and treated 1
  • If the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 1

Clinical Considerations

  • A meta-analysis of 12 randomized clinical trials showed azithromycin and doxycycline are equally efficacious for genital chlamydial infections, with similar rates of mild-to-moderate side effects 3
  • For rectal chlamydia infections, doxycycline may be more effective than azithromycin, with studies suggesting efficacy rates of 99.6% for doxycycline versus 82.9% for azithromycin 7
  • Test-of-cure is not recommended for patients treated with the recommended regimens unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1
  • Consider retesting women approximately 3 months after treatment due to high risk of reinfection 1

Common Pitfalls and Caveats

  • Failure to ensure treatment of all sexual partners can lead to reinfection 1, 8
  • Inadequate adherence to multi-day treatment regimens may result in treatment failure, making single-dose azithromycin preferable in cases where compliance is a concern 1, 9
  • Not considering anatomical site of infection when selecting treatment (doxycycline may be preferred for rectal infections) 7
  • Failing to consider pregnancy status before prescribing doxycycline or ofloxacin, which are contraindicated during pregnancy 6, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.